Evidence map›Paper›PMID 40091883›Full record

ArticleThe journal of allergy and clinical immunology. Global2025

Outcomes of drug provocation tests in children with chronic complications and comorbidities: Case series.

Kouhei Hagino, Kiwako Yamamoto-Hanada, Seiko Hirai, Daisuke Harama, Marei Omori, Yasuaki Matsumoto, Daichi Suzuki, Kotaro Umezawa, Fumi Ishikawa, Kenji Toyokuni and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kouhei HaginoAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Kiwako Yamamoto-HanadaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Seiko HiraiAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Daisuke HaramaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Marei OmoriAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Yasuaki MatsumotoAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Daichi SuzukiAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Kotaro UmezawaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Fumi IshikawaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Kenji ToyokuniAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Tatsuki FukuieAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Yukihiro OhyaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A study demonstrated that drug provocation tests could be conducted in children with underlying diseases, enabling accurate diagnosis of drug allergy. The study investigators hope that their work will allow more children with underlying conditions to undergo drug provocation tests.

Indexed as

childrenchronic diseasedelabelingDrug allergydrug provocation test

Identifiers

PMID40091883
PMCPMC11909742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.